Study of Chemotherapy Side Effects in Cancer Patients: Non-invasive Optical Measurements of the Brain
The researcher study about the integration of NIDOI and psychometric testing with initiation
of active cytotoxic chemotherapeutic treatment.
The researcher study about the feasibility of NIDOI analysis in patients undergoing initial
cytotoxic chemotherapy for cancer and to explore associations in these optical parameters
between patient reported outcomes reflective of disruption of quality of life (QOL) and
chemobrain-mild cognitive impairment and to test the research hypothesis is that among
cancer patients, those who develop chemobrain symptoms will experience a greater mean
reduction in brain tissue oxygen saturation than those who do not.
Observational Model: Case-Only, Time Perspective: Prospective
monitoring chemotherapy side effects
symptoms associated with the chemobrain syndrome
Edward Nelson, MD
Beckman Laser Institute University of California Irvine
United States: Institutional Review Board
|Beckman Laser Institute Medical clinic||Irvine, California 92612|